• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 重症患者的 DVT 发生率和危险因素。

DVT incidence and risk factors in critically ill patients with COVID-19.

机构信息

Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.

Department of Tuberculosis and Respiratory Disease, Jinyintan Hospital, Wuhan, China.

出版信息

J Thromb Thrombolysis. 2021 Jan;51(1):33-39. doi: 10.1007/s11239-020-02181-w.

DOI:10.1007/s11239-020-02181-w
PMID:32607652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7324310/
Abstract

Few data are available on the incidence of deep vein thrombosis (DVT) in critically ill COVID-19 with thrombosis prophylaxis. This study retrospectively included 88 patients in the ICU with critically ill COVID-19 at Jinyintan Hospital in Wuhan, China. All patients underwent compression ultrasonography for identifying DVT. Firth logistic regression was used to examine the association of DVT with sex, age, hypoalbuminemia, D-dimer, and SOFA score. The median (interquartile range [IQR]) age and SOFA score of 88 patients were 63 (55-71) years old and 5 (4-6), respectively. Despite all patients receiving guideline-recommended low-molecular-weight heparin (LMWH) thromboprophylaxis, the incidence of DVT was 46% (95% CI 35-56%). Proximal DVT was recognized in 9% (95% CI 3-15%) of the patients, while 46% (95% CI 35-56%) of patients had distal DVT. All of the proximal DVT combined with distal DVT. Risk factors of DVT extension occurred in all distal DVT patients. As Padua score ≥ 4 or IMPROVE score ≥ 2, 53% and 46% of patients had DVT, respectively. Mortality was higher in patients with acute DVT (30%) compared with non-DVT (17%), but did not reach statistical significance. Hypoalbuminemia (odds ratio [OR], 0.17; 95% CI 0.06-0.05, P = 0.001), higher SOFA score (OR per IQR, 2.07; 95% CI 1.38-3.39, P = 0.001), and elevated D-dimer (OR per IQR, 1.04; 95% CI 1.03-1.84, P = 0.029) were significant DVT risk factors in multivariable analyses. High incidence of DVT was identified in patients with critically ill COVID-19, despite the use of guideline-recommended pharmacologic thromboprophylaxis. The presence of hypoalbuminemia, higher SOFA score, and elevated D-dimer were significantly independent risk factors of DVT. More effective VTE prevention and management strategies may need to be addressed.

摘要

在中国武汉金银潭医院的 ICU 中,有 88 例 COVID-19 危重症患者接受了血栓预防。所有患者均接受了压缩超声检查以确定 DVT。使用 Firth 逻辑回归检查 DVT 与性别、年龄、低蛋白血症、D-二聚体和 SOFA 评分的关联。88 例患者的中位(四分位距[IQR])年龄和 SOFA 评分为 63(55-71)岁和 5(4-6)。尽管所有患者均接受了指南推荐的低分子肝素(LMWH)血栓预防,但 DVT 的发生率为 46%(95%CI 35-56%)。近端 DVT 见于 9%(95%CI 3-15%)的患者,而 46%(95%CI 35-56%)的患者存在远端 DVT。所有近端 DVT 均与远端 DVT 合并。所有远端 DVT 患者均发生 DVT 扩展的危险因素。Padua 评分≥4 或 IMPROVE 评分≥2 的患者分别有 53%和 46%发生 DVT。与非 DVT 患者(17%)相比,急性 DVT 患者的死亡率更高(30%),但无统计学意义。低蛋白血症(比值比[OR],0.17;95%CI 0.06-0.05,P=0.001)、更高的 SOFA 评分(IQR 每分,2.07;95%CI 1.38-3.39,P=0.001)和升高的 D-二聚体(IQR 每分,1.04;95%CI 1.03-1.84,P=0.029)是多变量分析中 DVT 的显著危险因素。尽管使用了指南推荐的药物性血栓预防,但 COVID-19 危重症患者中仍存在较高的 DVT 发生率。低蛋白血症、更高的 SOFA 评分和升高的 D-二聚体是 DVT 的显著独立危险因素。可能需要制定更有效的 VTE 预防和管理策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/406d/7829223/a8f9a432c202/11239_2020_2181_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/406d/7829223/a8f9a432c202/11239_2020_2181_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/406d/7829223/a8f9a432c202/11239_2020_2181_Fig1_HTML.jpg

相似文献

1
DVT incidence and risk factors in critically ill patients with COVID-19.COVID-19 重症患者的 DVT 发生率和危险因素。
J Thromb Thrombolysis. 2021 Jan;51(1):33-39. doi: 10.1007/s11239-020-02181-w.
2
Deep vein thrombosis in noncritically ill patients with coronavirus disease 2019 pneumonia: deep vein thrombosis in nonintensive care unit patients.COVID-19 肺炎非危重症患者的深静脉血栓形成:非重症监护病房患者的深静脉血栓形成。
J Vasc Surg Venous Lymphat Disord. 2021 May;9(3):592-596. doi: 10.1016/j.jvsv.2020.08.028. Epub 2020 Sep 7.
3
Deep Vein Thrombosis in Hospitalized Patients With COVID-19 in Wuhan, China: Prevalence, Risk Factors, and Outcome.中国武汉 COVID-19 住院患者的深静脉血栓形成:患病率、危险因素和结局。
Circulation. 2020 Jul 14;142(2):114-128. doi: 10.1161/CIRCULATIONAHA.120.046702. Epub 2020 May 18.
4
Analysis of Risk Factors for Thromboembolic Events in 88 Patients with COVID-19 Pneumonia in Wuhan, China: A Retrospective Descriptive Report.中国武汉 88 例新冠肺炎肺炎患者血栓栓塞事件危险因素分析:回顾性描述性报告。
Med Sci Monit. 2021 Apr 11;27:e929708. doi: 10.12659/MSM.929708.
5
Deep vein thrombosis in hospitalized patients with coronavirus disease 2019.COVID-19 住院患者的深静脉血栓形成。
J Vasc Surg Venous Lymphat Disord. 2021 May;9(3):597-604. doi: 10.1016/j.jvsv.2020.09.010. Epub 2020 Oct 8.
6
Clinical and laboratory characteristics of patients with novel coronavirus disease-2019 infection and deep venous thrombosis.新型冠状病毒感染和深静脉血栓形成患者的临床和实验室特征。
J Vasc Surg Venous Lymphat Disord. 2021 May;9(3):605-614.e2. doi: 10.1016/j.jvsv.2020.10.006. Epub 2020 Oct 22.
7
Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels.COVID-19 肺炎伴 D-二聚体升高患者无症状性深静脉血栓形成的发生率。
Thromb Res. 2020 Aug;192:23-26. doi: 10.1016/j.thromres.2020.05.018. Epub 2020 May 13.
8
SARS-CoV-2 and finding of vein thrombosis: can IMPROVE and IMPROVEDD scores predict COVID-19 outcomes?SARS-CoV-2 与静脉血栓形成的关系:IMPROVE 和 IMPROVEDD 评分能否预测 COVID-19 的结局?
Eur Rev Med Pharmacol Sci. 2021 Feb;25(4):2123-2130. doi: 10.26355/eurrev_202102_25118.
9
Utility of d-dimer for diagnosis of deep vein thrombosis in coronavirus disease-19 infection.新型冠状病毒感染中 D-二聚体对深静脉血栓形成的诊断价值。
J Vasc Surg Venous Lymphat Disord. 2021 Jan;9(1):47-53. doi: 10.1016/j.jvsv.2020.07.009. Epub 2020 Jul 30.
10
Incidence of deep venous thrombosis in COVID-19 critically ill patients treated with intermediate-dose of heparin for thromboprophylaxis: The COVIDOP-DVT observational study.COVID-19 危重症患者接受中等剂量肝素预防血栓形成治疗后的深静脉血栓发生率:COVIDOP-DVT 观察性研究。
Vascular. 2024 Oct;32(5):1099-1106. doi: 10.1177/17085381231165083. Epub 2023 Apr 3.

引用本文的文献

1
Profiling of lipid mediators and oxylipins in SARS-CoV-2 infection associated thrombosis.新冠病毒感染相关血栓形成中脂质介质和氧化脂质的分析
Sci Rep. 2025 Aug 29;15(1):31904. doi: 10.1038/s41598-025-17722-7.
2
Effect of mild-to-moderate COVID‑19 on the incidence and risk factors for deep vein thrombosis in patients with hip fracture: a retrospective study.轻度至中度新型冠状病毒肺炎对髋部骨折患者深静脉血栓形成发生率及危险因素的影响:一项回顾性研究
BMC Surg. 2025 Mar 24;25(1):113. doi: 10.1186/s12893-025-02831-x.
3
Predictors of venous thromboembolic events in hospitalized patients with COVID-19.

本文引用的文献

1
Computed tomography pulmonary perfusion imaging and 3-months clinical outcomes after acute pulmonary embolism.急性肺栓塞后计算机断层扫描肺灌注成像及3个月临床结局
Thromb Res. 2021 Mar;199:32-34. doi: 10.1016/j.thromres.2020.12.010. Epub 2020 Dec 19.
2
Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration.COVID-19 住院患者的抗凝干预措施:随机对照试验的范围综述及国际合作呼吁。
J Thromb Haemost. 2020 Nov;18(11):2958-2967. doi: 10.1111/jth.15094. Epub 2020 Oct 1.
3
Risk of venous thromboembolism associated with totally implantable venous access ports in cancer patients: A systematic review and meta-analysis.
新型冠状病毒肺炎住院患者静脉血栓栓塞事件的预测因素
J Thromb Thrombolysis. 2025 Apr;58(4):485-496. doi: 10.1007/s11239-025-03078-2. Epub 2025 Mar 10.
4
Unveiling the complexities of catheter-related thrombosis: risk factors, preventive strategies, and management.揭示导管相关血栓形成的复杂性:危险因素、预防策略及管理
J Thromb Thrombolysis. 2025 Mar;58(3):443-457. doi: 10.1007/s11239-025-03073-7. Epub 2025 Mar 5.
5
Prognostic factors in hospitalized patients with COVID-19 pneumonia and effectiveness of prophylactic anticoagulant therapy: a single-center retrospective study.新型冠状病毒肺炎住院患者的预后因素及预防性抗凝治疗的有效性:一项单中心回顾性研究
BMC Infect Dis. 2025 Mar 3;25(1):303. doi: 10.1186/s12879-025-10666-3.
6
Extensive Left Ventricular Thrombosis after Recovery from COVID-19: A Case Report.新冠病毒感染康复后出现广泛左心室血栓形成:一例报告
Tanaffos. 2024 Jan;23(1):93-96.
7
Transformative Deep Vein Thrombosis Prophylaxis With Sequential Compression Devices in the Care of Hospitalized Patients.在住院患者护理中使用序贯加压装置进行变革性深静脉血栓预防
Cureus. 2024 Oct 1;16(10):e70639. doi: 10.7759/cureus.70639. eCollection 2024 Oct.
8
Clinical characteristics and outcomes of venous thromboembolism in patients hospitalized for COVID-19: Systematic review and meta-analysis.因新冠肺炎住院患者静脉血栓栓塞症的临床特征及预后:系统评价与荟萃分析
Thromb Update. 2021;2:100037. doi: 10.1016/j.tru.2021.100037. Epub 2021 Mar 19.
9
Venous Thromboembolism and Associated Factors in Hospitalized Patients with COVID-19 at Addis Ababa COVID-19 Field Hospital, Ethiopia.埃塞俄比亚亚的斯亚贝巴新冠疫情野战医院新冠肺炎住院患者的静脉血栓栓塞症及相关因素
Infect Drug Resist. 2024 Jan 26;17:305-317. doi: 10.2147/IDR.S449401. eCollection 2024.
10
Comparison of Standard Versus Intermediate Prophylaxis Dose for Venous Thromboembolism Prophylaxis in Patients Hospitalized With COVID-19 Infection.新冠病毒感染住院患者静脉血栓栓塞症预防中标准剂量与中等剂量预防用药的比较
Hosp Pharm. 2024 Feb;59(1):94-101. doi: 10.1177/00185787231194997. Epub 2023 Aug 26.
癌症患者使用完全植入式静脉输液港相关的静脉血栓栓塞风险:系统评价和荟萃分析。
J Thromb Haemost. 2020 Sep;18(9):2253-2273. doi: 10.1111/jth.14930. Epub 2020 Jul 15.
4
Venous Thromboembolism Complicated with COVID-19: What Do We Know So Far?COVID-19 相关静脉血栓栓塞症:目前我们了解多少?
Acta Haematol. 2020;143(5):417-424. doi: 10.1159/000508233. Epub 2020 May 12.
5
Acute Pulmonary Embolism Associated with COVID-19 Pneumonia Detected with Pulmonary CT Angiography.通过肺部CT血管造影术检测到的与COVID-19肺炎相关的急性肺栓塞
Radiology. 2020 Sep;296(3):E186-E188. doi: 10.1148/radiol.2020201544. Epub 2020 Apr 23.
6
Acute Pulmonary Embolism in Patients with COVID-19 at CT Angiography and Relationship to d-Dimer Levels.新型冠状病毒肺炎患者急性肺栓塞的CT血管造影表现及其与D-二聚体水平的关系
Radiology. 2020 Sep;296(3):E189-E191. doi: 10.1148/radiol.2020201561. Epub 2020 Apr 23.